Purdue University

Purdue e-Pubs
Weldon School of Biomedical Engineering Faculty
Working Papers

Weldon School of Biomedical Engineering

9-2019

More Anatomically Realistic and Quantitative
Models of Pulmonary Surfactant Action and
Alveolar Stability
Charles F. Babbs
Purdue University, babbs@purdue.edu

Follow this and additional works at: https://docs.lib.purdue.edu/bmewp
Recommended Citation
Babbs, Charles F., "More Anatomically Realistic and Quantitative Models of Pulmonary Surfactant Action and Alveolar Stability"
(2019). Weldon School of Biomedical Engineering Faculty Working Papers. Paper 21.
https://docs.lib.purdue.edu/bmewp/21

This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact epubs@purdue.edu for
additional information.

More anatomically realistic and quantitative models of
pulmonary surfactant action and alveolar stability
Charles F. Babbs, MD, PhD
Weldon School of Biomedical Engineering, Purdue University,
West Lafayette, Indiana, 47907, USA
September, 2019

ABSTRACT
To explore basic mechanisms of action of pulmonary surfactant in preventing alveolar collapse, a
first-principles analysis is done analyzing forces on the shared walls separating adjacent alveolar
gas bubbles. The analysis holds for concave alveolar models with either rounded, dome-like
surfaces or flat, box-like surfaces. The analysis also holds for neighboring alveoli of varying
size and shape. Surfactant action is characterized by two parameters describing reduction in
surface tension vs. log concentration. The resulting equations describe the net pressure tending to
shift the shared position of a wall, as a function of the perturbation from a balanced initial state.
In the absence of surfactant, the bubbles exist in an unstable equilibrium. Any perturbation
causes runaway positive feedback such that one bubble shrinks and the other enlarges. In the
presence of surfactant having adequate concentration and potency the initial normal bubble
volumes are maintained by stabilizing negative feedback. With borderline surfactant activity
there is stable partial enlargement of one bubble and partial shrinkage of the other bubble. The
present analysis shows quantitatively how pulmonary surfactant normally works to equalize the
sizes of neighboring alveolar gas bubbles in small, local regions of lung. Once a threshold
surfactant effect is exceeded this local stability is robust. However, inadequate surfactant can
lead to microatelectasis, intrapulmonic shunting of venous blood past poorly alveoli, and arterial
hypoxemia. The presence of giant alveoli surrounded by smaller collapsed alveoli, as well as the
presence of hyaline membranes, characteristic of respiratory distress syndrome of the newborn,
are also explained by the underlying biomechanics.
Keywords: alveolar collapse, alveoli, atelectasis, hyaline membrane disease, neonatal, RDS,
respiratory distress syndrome of the newborn, surface tension.
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1. INTRODUCION
Normal lung function depends upon the presence of a pulmonary surfactant, a complex mixture
of detergent-like molecules that stabilizes the sizes of alveolar gas bubbles, presumably by
reducing surface tension. Lack of sufficient surfactant at birth results in respiratory distress
syndrome (RDS) of the newborn, a severe lung disease that can be reversed by treatment with
intrapulmonary natural or semi-synthetic surfactants1. In patients experiencing prolonged
cardiopulmonary bypass for cardiac surgery there can be patchy atelectasis associated with
decreased pulmonary surfactant (“pump lung”)2. There is also a decrease of surfactant in the
lungs of cigarette smokers3 and in cases acute respiratory distress syndrome (ARDS) with
surfactant insufficiency.
Natural pulmonary surfactant is a mixture of dipalmitoylphosphatidylcholine (DPPC), other
phospholipids, neutral lipids, hydrophilic and hydrophobic apoproteins (SP-A, B, C, and D), and
other proteins4, 5. In healthy individuals, pulmonary surfactant is secreted by Type II alveolar
cells and distributes to the surfaces of alveolar gas bubbles. The phospholipids have hydrophilic
“heads” and hydrophobic “tails”, and are thought to distribute on the surface of the alveolar gas
bubble with their tails facing the bubble lumen, reducing surface tension as a function of their
concentration per unit area. The surfactant layer can be oligolamellar, rather than a true
monolayer layer6. Natural lung surfactant contains less than 40% of the most effective,
disaturated phospholipids, such as DPPC. Accordingly, increased surfactant activity may happen
by a “squeeze out” mechanism5, in which less effective surfactants in the mixture, such as
unsaturated phosphatidylcholine (PC) and phosphatidylglycerol (PG) are squeezed out of the
surface monolayer, if its surface area decreases, increasing or enriching the concentration of
DPPC, which has two hydrophobic alkyl chains7 and can be over 100 times more effective than
the corresponding monomeric phospholipids8. This squeeze out model predicts that as bubble
size decreases, the effective DPPC concentration increases, and in turn, the surface tension
decreases.
Classical studies9 repeated many times10-12 demonstrate that elastic recoil pressures in lungs
inflated with saline solution are substantially less at any given volume than those measured in
lungs inflated with air. This simple experiment demonstrates air-water surface tension is
responsible for a large part of the elastic recoil pressure of the lungs. That is, the larger part of
the total retraction forces of the lung is ascribable to forces of surface tension.
Early on, 20th century textbooks of physiology described the tendency of alveolar gas bubbles to
collapse, and the corresponding physiological importance of surfactant in reducing surface
tension, using the law of Laplace (tension = transmural pressure  radius / 2) applied to two
spherical alveolar gas bubbles, connected by branched tubular airways—a “ball and stick” or
“balloon and tube” model (Figure 1)13.
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Figure 1. Traditional balloon and tube model explaining alveolar instability without
surfactant. At certain critical times in the ventilatory cycle there can be net transfer of
gas from smaller to larger alveoli in the absence of pulmonary surfactant.

An emergent property of this model and is that if a smaller Laplacian bubble of radius, r1, is
connected internally to a larger one of radius, r2, with the same surface tension, T, then there is a
tendency for unequal pressure, P1 = 2T/r1 > P2 = 2T/r2, to force air from the smaller bubble into
the larger one, at least during certain brief intervals in the ventilation cycle when P1 > Paw > P2
for common airway pressure, Paw .
This hypothetical system exhibits an unstable equilibrium. If r1 = r2 exactly, the interconnected
bubbles remain the same size. If one or the other radius is changed, however, the smaller one
will collapse into the larger one, creating an abnormal state quite similar to that observed in
respiratory distress syndrome (RDS) of the newborn, in which there is a deficiency of pulmonary
surfactant and in which microscopically, a small number of hyperinflated alveoli are seen,
surrounded by a larger number of collapsed alveoli14.
In a general and qualitative way, it is suggested that pulmonary surfactant can stabilize this
system by reducing surface tension, either in a crude sense by reducing surface tension to zero or
to negligible levels, so that the Law of Laplace becomes irrelevant, or in a more sophisticated
sense by reducing surface tension in an area-dependent manner, when a constant amount of
surfactant is distributed over a varying alveolar surface area. As alveolar radius, r, decreases, the
area becomes less and the surfactant concentration increases, which in turn reduces surface
tension, opposing the tendency of the smaller gas bubble to collapse.
In addition to being qualitative, and not quantitative, this simple Laplacian model has been
critically challenged by a number of thinkers. Prange13 has suggested that “the Y-tube model of
the alveolar inflation and the bunch-of-grapes model of alveolar anatomy deserve a place, not in
3

our minds and textbooks, but in the museum of wrong ideas”. This critique is based upon
several major differences between the assumed architecture of the model and the actual
microscopic anatomy of the lung. In particular, (1) alveoli are not shaped like spheres; they are
shaped like multifaced polyhedra, open on one side, with multiple flat sided facets. (2) Alveoli
are not directly connected to the smallest tubular airways, but rather clustered together in
alveolar ducts or sacs. They do not resemble individual balloons; rather, they have a sponge-like
open architecture, arranged around the common atrium of the alveolar sac. (3) Alveoli often
share common walls and are often directly interconnected by small alveolar pores of Kohn.
Fung15 has also emphasized that at the alveolar level the balloon and tube model is
“topologically wrong” and “both sides of each pulmonary alveolar septum are exposed to air at
the same pressure”. Further issues with the balloon and tube model have been raised by Hills16,
who suggested that “the validity of the conventional bubble model is clearly dependent on nearzero surface tension (< 5 mN/m)”, as well as other shortcomings17. Nevertheless, this model
continues to be taught in the 21st century, appearing in review articles18, in textbooks19-21 and in
online study guides, lecture notes, flashcards, and You-Tube videos (For examples, search “Law
of Laplace and alveolar collapse”.)
The present paper presents a revised and neoclassical model of alveolar collapse and stability
that preserves the simplicity and explanatory power of the original two bubble model but
circumvents some of its anatomic limitations. This new model is also quantitative rather than
qualitative. The essential feature is that neighboring alveoli within the same alveolar sac (or
back-to-back neighboring sacs) have shared, common walls between them, such that the forces
created by surface tension in neighboring bubbles oppose each other. In the absence of
surfactant, any pair of side by side or back to back bubbles is unstable, because if one bubble
gets slightly smaller, the opposing pressures on the shared wall will become unbalanced, shifting
the wall further toward the smaller bubble. Thereafter, owing to the tendency of surface tension
to minimize the surface area, the smaller bubble will assume a roughly similar, but smaller
shape, and the larger bubble will assume a roughly similar but larger shape, subject to local
boundary conditions. This cycle will be repeated in a runaway fashion, causing the arrangement
of “giant alveoli”, surrounded by many smaller, mostly collapsed alveoli, which are
characteristic of respiratory distress syndrome of the newborn.
This simple system of adjacent bubbles is easy to analyze in terms of the underlying biophysics
and may describe the essential features of alveolar collapse in conditions such as respiratory
distress syndrome of the newborn. What follows is a quantitative description of the underlying
biomechanics for either round sided or flat sided alveolar models. The dose-effect curve for
surfactant and the critical amount of surfactant needed to stabilize the system are also specified
quantitatively. The bubble equations and the surfactant equations are combined to create a
mathematical model of alveolar stability.
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2. THEORY
2.1 More atomically realistic model
As an alternative to the traditional balloon and tube model, Figure 2 illustrates a more
anatomically realistic, neoclassical model, which includes adjacent alveolar gas bubbles in a
particular alveolar duct or sac. These bubbles share walls with other alveoli, either in the same
alveolar sac (bottom) or in a neighboring alveolar sac (top). The alveolar gas bubbles are of an
arbitrary, concave, or dome-like shape, resembling partial pohyhedra, having a characteristic
length, s, such as the time-averaged diameter over one ventilatory cycle. (The change in volume
over a ventilatory cycle of normal quiet breathing is only about 7%**.) The neighboring alveolar
gas bubbles tend to make contact by way of the shared flat surfaces of the polyhedra (shaded
region in Figure 2).
Now consider a movable patch of the shared wall between bubbles 1 and 2 having an arbitrary
shape and constant area, awall. Let this patch be denoted W. Note that W may or may not contain
a small alveolar pore. Consider also the partial perimeters, shown as dotted curves in Figure 2.
These perimeters are selected such that the force of surface tension along each perimeter is
perpendicular to W.

**

To estimate the change in diameter during normal quiet breathing, where volume, V, is proportional to the cube

of side length, s, we can use

𝑉−∆𝑉
𝑉

= 1−

∆𝑉
𝑉

∆𝑠 3

∆𝑠

𝑠

𝑠

= (1 − ) or

3

= 1 − √1 −

∆𝑉
𝑉

. For example, in an adult, we might

have V = FRC + TV = 2500 ml and V = TV = 500 ml, with V/V = 1/5 and s/s  0.07. Similarly, in a neonate we
might have V = FRC + TV = 35 ml/kg and V = TV = 7 ml/kg, with V/V = 1/5 and s/s  0.07.
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Figure 2. Sketch of alternative biomechanical model of three adjacent alveolar gas
bubbles sharing common walls, some of which might include alveolar pores. Target
patch, W, of shared wall having area, awall, is shown as shaded region. Airway pressure,
P, is locally uniform. The gas bubbles may have arbitrary, dome-like shapes, ranging
from partial spheres to flat sided boxes. Characteristic dimensions s1 and s2 may differ.
The walls may be smooth or may be buckled or wrinkled in partial collapse.

Let the partial circumference of this perimeter in a plane parallel to wall W in bubble 1 be
denoted c1 , and let the area of the plane of the perimeter parallel to the surface of W be denoted
A1 . Let the partial circumference of the corresponding perimeter in bubble 2 be denoted c2 , and
let the corresponding plane area be denoted A2 . For bubbles of characteristic lengths, s, the
circumferences, c, are proportional to s, and the areas A are proportional to s2, so that
𝑐

1

= 𝜑𝑠
𝐴

(1)

for a shape factor,  . For hemispheres of diameter, d = s, open at the bottom, the shape factor is
𝑐
𝐴

1

= 𝜑𝑠 =

1
𝜋𝑑
2
1 𝑑 2
𝜋( )
2 2

, so that  = 4. Similarly, for a half hexagon, open at the bottom, the
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corresponding shape factor is 4.62, and for a full hexagon, open at the bottom at one side, the
shape factor is 3.85 (calculations not shown). Most compact alveolar geometries would have
shape factors near 4.** Hence, in vivo, shape factors may differ modestly, but not greatly.
If wall patch, W, moves from left to right in Figure 2, then the volume of bubble 1 will expand
and the volume of bubble 2 will shrink. Because the walls of each bubble have surface tension,
they will adjust to form minimal surface area shapes of the same general design, such as
hemispheres or boxes, depending on the local anatomical constraints provided by the tensile
matrix of connective tissue in the alveolar septae. However, the movement of the shared wall
still allows one bubble to expand and the other bubble to contract.
Now consider the balance of forces acting on W, with forces acting on area, awall, from left to
right in Figure 2 considered positive. In bubble 1 the force from internal pressure, P, on the
shared wall is P awall . This force is opposed by surface tension, T1, in bubble 1, which creates an
inward directed force acting along the perimeter of the bubble in a direction normal W. This
counterbalancing horizontal force from wall tension opposes the force of gas pressure on W.
The magnitude of the net force from bubble 1 pushing on W from left to right is
𝐹1 = 𝑃𝑎𝑤𝑎𝑙𝑙 − 𝑇1 𝑐1

𝑎wall
𝐴1

.

(2)

Here the total force of surface tension is T1c1. The fraction

𝑎𝑤𝑎𝑙𝑙
𝐴1

describes the proportion of the

total force of surface tension acing on W. Similarly, the magnitude of the net force from bubble
2 pushing on W from right to left is
𝐹2 = 𝑃𝑎𝑤𝑎𝑙𝑙 − 𝑇2 𝑐2

𝑎𝑤𝑎𝑙𝑙
𝐴2

.

(3)

Because the two alveoli are derived from the same alveolar sac or very closely neighboring
alveolar sacs, as well as because of the presence of alveolar pores, the air pressure, P, has the
same magnitude in both alveoli. The net pressure difference across W in the positive, left to
right (1 to 2) direction is
𝑃𝑛𝑒𝑡 =

𝐹1 − 𝐹2
𝑎𝑤𝑎𝑙𝑙

𝑐

𝑐

= 𝑇2 𝐴2 − 𝑇1 𝐴1 =
2

1

𝑇2 𝜑2
𝑠2

−

𝑇1 𝜑1
𝑠1

,

(4)

for shape factor, , which may change as a function of s1 and s2. (A similar analysis for one
sided, but not counterbalancing, retraction forces at plane interfaces was described in the year
1975 by Reifenrath22 (pages 123-124)). Now, without surfactant, if T1 = T2 = T, the common
**

For cubes of side, s, open at the bottom, for example, the shape factor is

𝑐
𝐴

1

3𝑠

𝑠

𝑠2

=𝜑 =

, so that  = 3. For tall,

narrow open-bottom rectangles of short side, s, and tall side, b, the shape factor,  = (2b+s)/(bs), approaches 2 as
short side span, s, approaches zero. For short, wide open-bottom rectangles of wide side, s, and short side, b, the
shape factor,  = (2b+s)/(bs), approaches infinity as b approaches zero. If one bubble collapses into its neighbor
there might be some systematic change in the shape factor, opposed to some degree by the effects of surface tension
that minimize surface area and perimeters toward more compact configurations.
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surface tension of water, and if 1 = 2 for simplicity, then equation (4) clearly implies positive
feedback. As the wall moves from left to right, bubble 1 will get bigger and bubble 2 will get
smaller, further increasing the net positive pressure on W.
To characterize the size relative changes of neighboring alveolar gas bubbles, let  denote the
|𝛥𝑠|
absolute value of the fractional change in bubble dimensions, 𝑠 , caused by movement of W,
where s is the average initial value of local alveolar dimensions during the ventilatory cycle,
and |s| is the absolute value of septal shift in Figure 2. In this case surfactant concentration in
|∆𝑠|
|∆𝑠|
each bubble wall changes as a function of 𝜀1 = 𝑠 and of 𝜀2 = 𝑠 with subscript 0 indicating
10

20

the initial conditions. Then 𝑠1 = 𝑠10 (1 + 𝜀1 ) and 𝑠2 = 𝑠20 (1 − 𝜀2 ).
2.2 Surfactant effect
A remarkable property of the surfactant that coats the walls of alveolar gas bubbles is that it
reduces the surface tension by a factor of up to fifteen23-25. Surfactants typically reduce surface
tension in a concentration-dependent manner, as shown in Figure 3. The semi-logarithmic
relationship is that most frequently found experimentally8, 26, 27. Surface tension of saline at
37°C , Tmax, is about 70 mN/m7. For tiny concentrations of surfactant, there is no effect. Then
after a critical minimal concentration, c0 , is reached, the “breaking point” of the curve, surface
tension decreases as a linear function of the logarithm of the concentration until a maximal
reduction is achieved, after which further increases in surfactant concentration have no additional
effect. As shown in Figure 3, curves of this type can be described simply by the piecewise linear
function of the log surfactant concentration, c , in the liquid phase as follows:
𝑇 = 𝑇𝑚𝑎𝑥 , c < c0
𝑙𝑛(𝑐/𝑐0 )

𝑇 = 𝑇𝑚𝑎𝑥 (1 − 𝛽 𝑙𝑛(𝑐

) , c0  c  cmax

𝑚𝑎𝑥) /𝑐0 )

(5)

𝑇 = 𝑇𝑚𝑎𝑥 (1 − 𝛽) , c > cmax ,
where  is the maximal fractional reduction in surface tension produced by a particular
surfactant, which is a measure of its “pharmacodynamic effect”.
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breaking point
Tmax

T(mN/m)


log( c / c0 ) 

T  Tmax 1 − 
log( cmax / c0 ) 


Tmin
0
ln(c0)

ln(cmax)
Ln concentration, c

Figure 3. Typical dose response curve for a surfactant redrawn from (Trillo, 2014)8.
Dashed curve shows piecewise linear approximation. Ln indicates the natural logarithm.

9

Initially, the time-averaged concentration of surfactant on the surface of each alveolar bubble is
some specified nominal or normal value, cn , which we assume in the present model is constant
over the many cycles of ventilation, such that for variable concentration, c(), we have
𝑐𝑠 2 = 𝑐𝑛 𝑠𝑛2 or 𝑐𝑠𝑛2 (1 + 𝜀)2 = 𝑐𝑛 𝑠𝑛2 . , where, as before, the variable, , denotes the fractional
change in gas bubble size. The influence of relative area on local surfactant concentration
during small changes in alveolar volume has been demonstrated experimentally28-30 and
𝑐𝑛
theoretically31. In this case the concentration as a function of  is 𝑐 = (1+𝜀)
, and in the critical
2
range of interest to the right of the breaking point, c0  c  cmax ,
𝑇 = T𝑚𝑎𝑥 (1 − 𝛽

𝑐
𝑙𝑛( 𝑛 ∙

1
)
𝑐0 (1+𝜀)2
𝑐𝑚𝑎𝑥
𝑙𝑛(
)
𝑐0

),

(6)

or
𝑇 = T𝑚𝑎𝑥 (1 − 𝛽

𝑐
𝑙𝑛( 𝑛 )−2𝑙𝑛(1+𝜀)
𝑐0

𝑐
𝑙𝑛( 𝑚𝑎𝑥 )

).

(7)

𝑐0

Introducing the dimensionless constants
𝑎 =1−𝛽

𝑐
𝑙𝑛( 𝑛 )
𝑐0

,
𝑐
𝑙𝑛( 𝑚𝑎𝑥 )

(8)

,

(9)

𝑐0

and
𝑏=𝛽

2
𝑐
𝑙𝑛( 𝑚𝑎𝑥 )
𝑐0

to describe the nominal concentration and potency of a particular surfactant, then
𝑇 = 𝑇𝑚𝑎𝑥 (𝑎 + 𝑏 𝑙𝑛(1 + 𝜀)).

(10)

Constant, a , represents the fractional reduction in T before any wall shift, when  = 0. That is,
a = T/Tmax . Moreover, accounting for surfactant effect, when the bubble dimension increases by
 , surface tension increases, rather than remaining constant, as shown experimentally by Smith
and Stamenovic32.
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2.3 Combined force balance and surfactant effects
𝛥𝑠

Now, as before, let  denote the absolute value of the fractional change in bubble dimensions, 𝑠
that is caused by movement of W, where s is the average initial value of local alveolar
dimensions in time during the ventilatory cycle. In particular, 𝑠1 = 𝑠10 (1 + 𝜀1 ) and 𝑠2 =
𝑠20 (1 − 𝜀2 ). Then the pressure difference across the shared wall between neighboring bubbles is
simply
𝑇2 𝜑2
20 (1−𝜀2 )

𝑃𝑛𝑒𝑡 = 𝑠

−

𝑇1 𝜑1
𝑠10 (1+𝜀1 )

.

(11a)

To add the effect of a modest change in shape factor, , which in view of the forgoing examples
will be most likely within the range of about 3.5 to 4.5, as neighboring bubbles stretch and
shrink; consider a simple linear model. In this sub-model d/ds = k, a small constant. Then
𝜑1 = 𝜑10 (1 + 𝑘𝜀1 ) and 𝜑2 = 𝜑20 (1 − 𝑘𝜀2 ) . That is, as wall shift occurs, bubble 1 may
become a little more rounded with  closer to 4, and bubble 2 may become a little more flattened
with  closer to 3. For this varying shape factor model
𝑃𝑛𝑒𝑡 =

𝑇2 𝜑20 (1−𝑘𝜀2 )
𝑠20 (1−𝜀2 )

−

𝑇1 𝜑10 (1+𝑘𝜀1 )
𝑠10 (1+𝜀1 )

.

(11b)

For neighboring bubbles differing in initial size but remaining similar in shape k = 0. The goal
in what follows is to explore the stability of the neighboring bubble system in response to small
mechanical changes, , in the alveolar dimensions caused, for example, by slight differences in
lung elastic recoil, or perhaps small transient differences in patency of respiratory bronchioles
serving neighboring alveolar sacs.
Substituting surfactant dependent surface tensions for T1 and T2 in Equation (11b),
(𝑎+𝑏 𝑙𝑛(1−𝜀2 ))𝜑20 (1−𝑘𝜀2 )

𝑃𝑛𝑒𝑡 = 𝑇𝑚𝑎𝑥 (

𝑠20 (1−𝜀2 )

−

(𝑎+𝑏 𝑙𝑛(1+𝜀1 ))𝜑10 (1+𝑘𝜀1 )
𝑠10 (1+𝜀1 )

) .

(12)

For purposes of perturbation analysis for any particular pair of alveoli, consider an initial
equilibrium, which may or may not be stable, as the starting point for the analysis. In this
𝜑
𝜑
starting scenario we would have 1 = 2 = 0, and also Pnet = 0. Then 0 = ( 𝑠 20 − 𝑠 10 ) , or
𝜑20
𝑠20

=

𝜑10
𝑠10

20

10

≡ 𝐾 , a constant. Now for purposes of perturbation analysis for any particular pair of

alveoli, we can consider dimensionless pressure difference across a particular patch of shared
alveolar wall, Pnet/(KTmax), as
𝑝=

(𝑎+𝑏 𝑙𝑛(1−𝜀2 ))(1−𝑘𝜀2 )
1−𝜀2

−

(𝑎+𝑏 𝑙𝑛(1+𝜀1 ))(1+𝑘𝜀1 )
1+𝜀1

.

(13a)
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Further, because of the wall shift with dimension s1 increasing and dimension s2 decreasing, each
𝑠
by the same absolute amount, s = 1s10 = 2s20, we have 𝜀2 = 𝑠10 𝜀1 ≡ 𝜆𝜀1 for constant 
20

depending on the initial size difference in alveolar gas bubbles 1 and 2. In this case
𝑝=

(𝑎+𝑏 𝑙𝑛(1−𝜆𝜀1 ))(1−𝑘𝜆𝜀1 )
1−𝜆𝜀1

−

(𝑎+𝑏 𝑙𝑛(1+𝜀1 ))(1+𝑘𝜀1 )
1+𝜀1

(13b)

for −1 < 𝜀1 < 𝜆𝜀1 , as a function of 1 only.
When the fractional change in bubble size, 𝜀1 = 0 , then 𝑝 = 0 , as expected.
In this way the neighboring bubble model and the surfactant effect model can be combined to
describe the critical equilibriums for airway collapse or stability in terms of runaway or
compensatory motion of the shared wall. All model parameters are defined on the basis of
physics, anatomy, chemistry, and physiology. There are no free parameters or arbitrary
constants.

2.4 Values of critical constants
Analysis of experimental data can be done to find the values of constants a and b in Equation
(13b). For normal alveoli the surfactant concentration cn produces an in vivo surface tension of
25 mN/m23 in vitro in experiments on surfactant bubble films, and values ranging from about 10
to 25 mN/m in vivo33, 34. Taking a value of 18 mN/m as the initial operating point for our model,
and taking 70 mN/m as the surface tension for saline solution without surfactant, the value for
constant, a , in Equation (11) becomes
𝑎=𝑇

𝑇

18

𝑚𝑎𝑥

= 70 ≈ 0.257.

(14)

All that is needed to estimate constant, b, are two measured points in the linear range of surface
tension vs. log concentration, as described in the Appendix. Point 1 represents a state of high
surface tension and low surfactant concentration, and point 2 represents a state of lower surface
tension and increased surfactant concentration. As explained in the Appendix, the critical
variables for data analysis are ln(c2/c1) and (T1 − T2)/Tmax, where Tmax is the surface tension of
saline solution without surfactant.
The specific data dependent value for constant, b , in Equations (10) through (13b) is given by
𝑏=2

(𝑇1 −𝑇2 )/𝑇𝑚𝑎𝑥
𝑙𝑛(𝑐2 /𝑐1 )

(15)

with Tmax = 70 mN/m for saline solution, and the other variables coming from two measured data
points in a particular experiment, as shown in Table 1. A virtue of this approach is that only
relative values are needed, so concentration ratios can be inferred from measured bubble area
ratios, if necessary.
12

Table 1 presents the results of this analysis to extract representative values of constants a and b
from nine published experimental studies involving natural and synthetic surfactants. There is a
range of effectiveness of the surfactants in terms of lumped parameter, b. A middle value for use
in the standard model is b = 1.34, the average observed value.

TABLE 1. Curve fit constants from experimental data. T = T1 − T2.
Investigator (year)
Hallman (1976)
Barrow (1979) Fig 1
Schurch (1989) Fig 5
Seeger (1999) mixture
Seeger (1999) Curosurf
Walters (2000)
Possmayer (2001)
Scurch (2001)
Trillo (2014) Fig 5
Average

2T/Tmax
1.229
0.514
0.529
0.714
0.457
0.857
0.714
0.714
0.714

ln(c2/c1)
1.609
0.470
0.693
1.609
0.511
0.490
0.211
0.375
0.693

b
0.763
1.094
0.763
0.444
0.895
1.751
3.390
1.906
1.030
1.337

To estimate the size difference factor, , consider that most neighboring alveoli in a cluster will
be of similar size initially, with size difference factor, , being somewhat greater than 1.0 in
some cases and somewhat less than 1.0 in other cases. For an average or “typical” alveolus one
would expect 1+   2.
To estimate shape-change factor, k, we can expect on the basis of the forgoing geometric
analysis and the various test shapes that a typical normal alveolar shape constant would be   4.
This is the most likely scenario. In cases where there is systematic change in shape factor with
septal shift, the range of  would be perhaps 3.5 to 4.5. Thus for  = 1 we would have 4.5/4 = 1
 k, depending on which way the shape factor changes under local conditions. Hence, we might
expect k   0.125. An approximate working value for a standard model would be k = 0. To
explore possible reasonable changes in shape factor, one can study −0.2  k  0.2.
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3. RESULTS
3.1 Linear approximations
Before proceeding to exact numerical calculations, it is insightful to solve Equation (13b)
analytically for some simplified test cases. For small perturbations such as
1 = s/s1 << 1, both the inverse function and the logarithmic function of can be simplified using
binomial series or Taylor series expansions,
1
1+𝜀

≈ 1 − 𝜀 + 𝜀2 − 𝜀3 + ⋯

(16)

and
1

1

𝑙𝑛(1 + 𝜀) ≈ 𝜀 − 2 𝜀 2 + 3 𝜀 3 + ⋯.

(17)

Dropping terms for powers of  > 1 for small perturbations, the mathematics of Equation (13b)
become more clear. After using Equations (16) and (17) in Equation (13b), the dimensionless
transmural pressure difference, as a function of the fractional expansion, 1, of bubble 1 is
𝑝(𝜀1 ) ≈ (1 + 𝜆)(𝑎(1 − 𝑘) − 𝑏)𝜀1,

(18)

and the slope of the dimensionless transmural pressure,
𝑑𝑝
𝑑𝜀1

≈ (1 + 𝜆)(𝑎(1 − 𝑘) − 𝑏).

(19)

In the case of zero surfactant concentration the constant, a = 1, and the slope, , in Figure 3 is
zero, so that b = 0. The transmural pressure is proportional to any small volume offsets.
Equations (18) and (19) imply positive feedback and runaway collapse over the full range −1  
 1. However, for a particular surfactant compound, characterized by b > 0 , the value of
𝑎 =1−𝛽

𝑐
𝑙𝑛( 𝑛 )
𝑐0

𝑐
𝑙𝑛( 𝑚𝑎𝑥 )

becomes smaller, as the surfactant concentration, cn, becomes greater.

𝑐0

Eventually, for a(1 − k) < b , the slope of Equation (18) becomes less than zero over the full
range −1  1  1. Now if gas is shifted from bubble 1 to bubble 2 by some initial perturbation,
the wall of bubble 2 will be pushed backward into bubble 1, restoring equilibrium. Moreover,
the greater the initial offset, 1, in the positive direction, the more the compensating negative
pressure difference. Similarly, for a negative offset, 1 < 0, Equation (18) implies that for
a(1 − k) < b there will be compensating pressure in the positive direction. Under these
conditions the system is stable.
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3.2 Shared wall pressure
Figure 4 shows the exact solutions without surfactant (a = 1, b = 0) for shared wall pressure
(Equation (13)) compared with the linear approximation (Equation (18)) as a function of the
perturbation volume fraction, 1, for the two-bubble model. The point at 1 = 0 is the neutral or
equilibrium position. In the absence of surfactant, however, the origin is an unstable
equilibrium. The same type of positive feedback and runaway collapse is predicted by both the
exact and approximate solutions.

5

Dimensionless wall pressure, p

4

exact
approx

3
2
1
0

-1

-0.5

-1 0

0.5

1

-2
-3
-4
-5
Fractional change in size, 1

Figure 4. Perturbation analysis using transmural pressure without surfactant (a = 1, b =
0) as a function of the fractional offset, 1, in linear dimension. Curves represent exact
and approximate solutions. For shape factor 4, one dimensionless unit on the vertical
4∙0.070 𝑁/𝑚 0.0075 𝑚𝑚𝐻𝑔
axis equals 0.0001 𝑚 ∙
= 21 𝑚𝑚𝐻𝑔 . Shape parameters  = 1 and k = 0.
𝑁/𝑚2
Figure 5 shows the exact solutions with a mid-range concentration of a surfactant with properties
similar to that of biological pulmonary surfactant (Table 1). The chart shows dimensionless
transmural pressure, p, (Equation (13b)) and the linear approximation (Equation (18)) as a
function of the fractional perturbation in alveolar size, 1 , for the side by side, two-bubble
system. Now, for either the exact or approximate solutions, when the perturbation is positive,
the resulting wall pressure difference is negative, stabilizing the volumes of both bubbles. A
stable zero crossing point occurs at 1 = 0, since the slope of the function is negative at the zero
crossing. The magnitude of the compensating pressure is physiologically meaningful, on the
order of 20 mmHg per unit of dimensionless pressure.
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3
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0
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-4
-5
Fractional change in size, 1

Figure 5. Perturbation analysis with surfactant. a = 0.257, b = 1.34 , k = 0.0,  = 1
(standard normal model). A normal concentration and potency of surfactant can
stabilize the system for all possible perturbations. Curves represent exact and
approximate solutions. For shape factor 4, one dimensionless unit on the vertical equals
4∙0.070 𝑁/𝑚 0.0075 𝑚𝑚𝐻𝑔
∙
= 21 𝑚𝑚𝐻𝑔 .
0.0001 𝑚
𝑁/𝑚2

If an effective surfactant is present in sufficient concentrations, the origin is a stable equilibrium
(Figure 5). In general, if the wall pressure function, p(1) , is constrained to the “unstable
quadrants” 1 and 3 in Cartesian coordinates, there will be an unstable equilibrium. If the
function p(1) is constrained to the “stable quadrants” 2 and 4 in Cartesian coordinates, there will
be a stable equilibrium. For the particular values of constants a and b in Figure 5 there is
stability over the complete dynamic range of 1 from −1 to 1. The results of Figure 5, which
mimic the action of normal pulmonary surfactant, demonstrate the robustness of the surfactant
effects over the entire range of possible wall shifts.
The physics of the two-bubble system with adequate surfactant effect (a(1 − k) < b), is analogous
to the physics of a pendulum in the gravitational field at the Earth’s surface or of a simple spring
and mass system. If the mass at the end of the pendulum or at the end of the spring is pulled in
one direction, there will be a proportional restoring force directed toward the equilibrium
position. If the mass is pulled in the opposite direction there will be an oppositely signed
restoring force directed toward the equilibrium position.
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It is interesting to explore the region of transition between unstable and stable states for
gradually increasing amounts of surfactant activity. Figure 6 illustrates the effects of a series of
surfactant concentrations, specified by decreasing values of parameter, a . As surfactant action is
increased, the slope of the shared wall pressure function gradually decreases from positive to
negative. The greater the relative dose of the surfactant, the greater are the restoring pressures.

Dimensionless wall pressure, p

2

1

a=1.0,
b=0.0
a=0.8,
b=0.4

0

-1

-0.5

0

0.5

-1

1

a=0.3,
b=0.4
a=-0.5,
b=0.4

-2
Fractional change in size, 1

Figure 6. Perturbation analysis for increasing surfactant activity in terms of shared wall
pressure. Decreasing values of parameter, a, including a < 0, correspond to increasing
surfactant concentration. Shape parameters  = 1 and k = 0.
A closer look at the transition region for the exact solutions reveals interesting behavior. For
example, when a = 0.57 and b = 0.43 in Equation (13b) the results in Figure 7 are obtained.
There is one unstable equilibrium, and there are two stable equilibriums. If a small positive wall
shift, 1 > 0, occurs, then bubble 1 will continue to expand and bubble 2 will continue to shrink
until the downward sloping zero crossing point in Figure 7 is reached. There the system
becomes stable, because further positive wall displacement results in negative feedback. A
similar phenomenon happens for a small negative offset, 1 < 0.
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Dimensionless wall pressure, p

0.2

a = 0.57
b = 0.43

0.15

exact

0.1
0.05
0
-1

-0.5

-0.05

0

0.5

1

-0.1
-0.15
-0.2
Fractional change in size, 1

Figure 7. Perturbation analysis for a borderline case (a = 0.57, b = 0.43,  = 1, k = 0).
There are stable points at the two negatively sloping zero crossings near  0.5. Note the
expanded vertical scale compared to Figure 6.

3.3 Size and shape effects
Sensitivity of the results in Figures 4 through 7 to changes in the initial size mismatch factor, ,
and the shape factor change term, k, can be appreciated both analytically, by inspection of
Equations (18) and (19), and also numerically by evaluation of Equation (13b) for test cases.
Analytically, the slope of the stability function at 1 = 0 is given by Equation (19) as
𝑑𝑝/𝑑𝜀1 = (1 + 𝜆)(𝑎(1 − 𝑘) − 𝑏). The initial size mismatch factor,  = s01/s02 , is always
greater than zero. Hence changes in  will influence the magnitude of the slope somewhat, but
not the sign of the slope. That is, to first order, changes in  will not change the threshold
between stability and instability of the two-bubble system. The system is essentially stable if
𝑎(1 − 𝑘) < 𝑏 , and unstable otherwise. Thus, changes in the absolute value of k, representing
shape-factor change with gas transfer from one bubble to the other, will cause modest changes in
the threshold conditions for stability. Values of k < 0 will make the system somewhat less
stable, requiring greater surfactant activity to enforce stability. Values of k > 0 will make the
system somewhat more stable, requiring less surfactant activity to enforce stability. The general
requirement for some critical level of surfactant activity remains the same.
Figure 8 shows examples of numerical solutions for the exact expression of Equation (13b),
including nonlinear as well as linear effects. In this highly sensitive, borderline stable case any
changes in initial size mismatch parameter, , from the standard value of 1.0 cause subtle
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changes in slope both in the linear and nonlinear portions of the curve. The same is true when
the shape factor change term, k, is increased from 0 to 0.2 or decreased from 0 to − 0.2.
Qualitative behavior of the two-bubble system with two stable equilibrium points at negatively
sloping zero crossings is similar to that of the standard model in Figure 7.
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Figure 8. Sensitivity analysis for size and shape difference factors  and k with
a = 0.57, b = 0.43. When initial size mismatch parameter, , or shape factor change
parameter, k, is changed, there are still stable points at the two negatively sloping zero
crossings. Note the expanded vertical scales compared to Figure 6.
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4. DISCUSSION
The conventional qualitative explanation for the role of surfactant is that, once interconnected,
smaller bubbles would have higher internal pressures, and hence gas would flow from smaller
bubbles into larger ones until the smaller bubbles collapsed. In this way it has been taught that
surfactant protects against the collapse of alveoli and consequent formation of pulmonary edema,
which would happen otherwise as the net collapse pressure draws fluid from capillaries into the
alveolar spaces having smaller bubbles3, 35, leading to the shunting of venous blood past
unventilated alveoli, and profound arterial hypoxemia. In addition, the general reduction of
surface tension by surfactant reduces lung recoil, ‘‘making breathing easy’’36.
These teachings, however, are based on unrealistic anatomical assumptions that alveoli are
spherical bubbles, connected only by tubular airways, rather than dome-like or box-like
structures, often with flat sides, connected directly to the same alveolar sac and sharing common
alveolar walls with their neighbors. Moreover, the original balloon-and-tube model, based on the
Law of Laplace for spherical bubbles, is only qualitative or at best semi-quantitative. To fully
understand the physiological mechanism that normally controls alveolar gas bubble size, and
how it breaks down in conditions such as RDS, one needs to have a more anatomically realistic,
quantitative model.
The balance of forces described by Equations (13a) and (13b) provides a compact, quantitative
mechanism for the local instability of alveolar neighboring gas bubble size in the absence of
adequate surfactant, as well as for the local stability of neighboring alveolar gas bubble size in
the presence of adequate surfactant. The proposed mechanism for size stability works despite
the many natural complexities of the underlying living system, which include the angled corners
of non-spherical alveolar walls, deviation of the bubbles from a spherical shape at low surface
tensions37, the action of surfactant activity-boosting apoproteins4, lipids23, or drugs38, possible
degradation of surfactants by proteases or inhibition by plasma proteins24, and the existence of
surface tension–area hysteresis loops3. Moreover, the present approach easily incorporates
possible molecular mechanisms other than simple monolayering for surface tension reduction.
Such adjunct mechanisms include selective DPPC adsorption as well as recruitment of
apoproteins during bubble compression from multilayered raft-like or iceberg-like reservoirs
associated with the bubble surface7, 37. The same goes for synthetic or semi-synthetic surfactant
preparations, including additives to enhance their activity4. Effects of such complexities can be
incorporated into the lumped shape factor, , and the constants a and b.
An advantage of the present analysis and the associated mathematical model is that they
accommodate neighboring alveoli of various sizes and shapes in the initial conditions. Data exist
showing that the ratio of alveolar depth to alveolar mouth diameter changes with inflation under
certain conditions. Klingele and Staub39 measured the ratio of maximum depth to the opening or
mouth diameter of alveoli in anesthetized cates. This ratio was constant (0.89  0.02) for
inflation volumes at and above 50% of maximum lobe volume. However, the ratio progressively
increased for inflation volumes below 50%, indicating that the alveoli can became relatively
narrower. Such narrowing would tend to produce larger shape factors, , in the present
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mathematical model. There is one report that the alveolar septae may fold during deflation and
unfold on inflation40; however the authors conclude that the “folds form de novo during
experimental preparation; one need not postulate that septal folding was present in vivo.” In
addition, the ability of the present model to deal with initial conditions including different sized
alveoli is useful in view of anatomic observations showing some differences in diameters of
neighboring alveoli, even if the plane of section is taken into account41.
It is important to appreciate that the present analysis and mathematical model describe
neighboring alveoli in one alveolar sac. There is nothing in the mathematics that requires
average local alveolar diameters to be the same in different lobes of the lung. The initial
conditions are entirely local. The initial diameters, s10 and s20, become part of the normalization
factor for the scaled pressured difference, p, plotted in Figures 4 through 8. In such cases there
could well be different normal equilibrium sizes, s01 and s02, in different parts of the lung.
However, local consistency in gas bubble size will still be maintained. Similarly, the present
revised and augmented bubble model applies equally well to small animals with smaller alveolar
diameters43, 44 as well as to larger animals, such as humans, with larger alveolar diameters. Also,
the diameters s10 and s20 can be regarded as time averaged values throughout a ventilatory cycle,
varying by about 10 percent (tidal volume / functional residual capacity). In this sense the model
is valid over a wide domain of space and time.
Regarding shape factors of neighboring alveoli and divergence of shape factor values with septal
shift, one can argue rather convincingly that curvature dependent Laplace forces will cause an
individual partially flattened alveolar gas bubble to round-up and to become more uniformly
curved as much as possible, subject to local boundary conditions. Recall that actual gas/water
interfaces are not preserved in the usual histologic preparations for light microscopy. Hence, we
think of alveolar air spaces as more angulated than they really are. Shape factors would tend to
bunch near the hemispherical value of = 4, as described previously. Nevertheless, modest
linear changes in the shape factor in either direction with sepal shifts, described mathematically
by the constant, k, in Equations (11b) through (13b), cause only modest changes in stability
criteria, as shown, for example, in Figure 8 Overall, the perturbation analysis described here
model is robust with respect to differences in initial alveolar size and shape.
In the absence of adequate surfactant activity, the neighboring bubble model of Figure 2 and
Equation (13b) predicts local aggregation of gas volume into a few “giant” alveoli, with collapse
of neighboring alveoli in the region. This pattern of pathology is exactly that observed in realworld cases of respiratory distress syndrome of the newborn14, 42, which are characterized
microscopically by multiple collapsed alveoli surrounding hyper-aerated alveoli, which are often
lined with rims of amorphous protein deposits called hyaline membranes. Could the side by side
bubble model also explain the other hallmark feature of respiratory distress syndrome of the
newborn, namely the presence of hyaline membranes, which are composed of proteins and
occasionally fibrin42, lining the larger alveoli? Perhaps so.
Consider the shear stresses placed on a shared alveolar wall, containing a pulmonary capillary, as
shown in Figure 9. Here the circumference of the capillary includes three endothelial cells,
surrounding a plasma filled lumen containing one red blood cell, shown in dark shading. As one
neighboring bubble enlarges and the other shrinks, one side of the capillary wall is stretched and
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the other is compressed. This action may tend to pull apart cell-cell junctions between capillary
endothelial cells on the stretched side selectively. Small gaps might well appear on the large
bubble side of the capillary only. These gaps would be sufficiently wide to allow leakage of
plasma proteins including fibrin monomers and other clotting factors, but not wide enough to
allow escape of the much larger red blood cells. The leaked fibrin monomers would then tend to
cross-link, forming a cell-free hyaline protein gel. In this way the local asymmetry of shear
stress may explain the appearance of hyaline membranes within the larger, expanded gas
bubbles, rather than within the smaller, collapsed ones.

gas bubble 2

gas bubble 1

alveolar wall

Figure 9. Scheme for explaining the formation of hyaline membranes. Opposing shear
stresses tend to pull apart capillary endothelial cells on one side, allowing leakage of
plasma proteins.

Note also that without adequate surfactant the adjacent bubble model of Figure 2 implies a
cascading sequence of failure for clusters of multiple adjacent bubbles: A, B, C, D, …, within the
same alveolar sac. If bubble A becomes transiently smaller, it will shrink and cause expansion of
bubble B. Now, bubble B is larger than its other neighbor, C, which will tend to collapse into
bubble B as well. If bubble B has more than the two neighbors, A and C, call them D, E, and F,
originally of normal size, then those bubbles will also tend to collapse into B. This sequence
predicts the creation of single large bubbles, surrounded by multiple smaller ones in the absence
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of surfactant—exactly as is seen microscopically in cases of respiratory distress syndrome of the
newborn42.
The present theoretical treatment is, of course, highly simplified. Nevertheless, it does explain
many facets of normal and abnormal physiology, including why protection from alveolar
collapse provided by surfactant is normally quite robust, regardless of initial bubble diameter,
intrathoracic pressure, regional variation in lung ventilation, or modest differences in surfactant
composition or effectiveness; why without surfactant there are many tiny collapsed alveoli, and a
few hyper-expanded, giant alveoli in a low power microscopic field; why hyaline membranes
tend to appear mostly in larger alveoli; why there is not massive pulmonary edema in the lungs
of premature babies with RDS of the newborn; why an inadequate dose of surfactant can lead to
partial reversal without complete normalization of alveolar size disparity; why alveolar size
discrepancies between lung lobes are allowed; and why bats and shrews, reported to have very
small alveolar diameters compared to other mammals44, can maintain these small alveolar
diameters, even though smaller bubbles have higher transmural pressures.

5. CONCLUSIONS
The anatomically realistic adjacent bubble model described herein captures essential mechanisms
underlying the action of pulmonary surfactant. It provides quantitative expressions that
incorporate the physics of surface tension to explain how air-breathing land animals survive,
despite air-water surface tension in the lungs. It also explains the pathophysiology and
microscopic pathology of respiratory distress syndrome of the newborn, including the formation
of hyaline membranes.
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APPENDIX: estimation of constant, b, from experimental data
Consider two experimentally measured points 1 and 2 on the downward sloping linear range of
the chart in Figure 3 and Equation (6). Point 1 represents a state of high surface tension and low
surfactant concentration, and point 2 represents a state of lower surface tension and increased
surfactant concentration. The slope between these points is
𝑇 −𝑇

1
𝑠 = 𝑙𝑛(𝑐 2)−𝑙𝑛(𝑐
.
)
2

1

(20)

In terms of the constants c0 and cmax, representing the smallest and largest surfactant
concentrations on the complete linear portion of the curve in Figure 3 from Tmax to (1 − )Tmax ,
for maximum fractional reduction in surface tension,  , the slope of the middle linear portion is
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𝑠=

(1−𝛽)𝑇𝑚𝑎𝑥 −𝑇𝑚𝑎𝑥
𝑙𝑛(𝑐𝑚𝑎𝑥 )−𝑙𝑛(𝑐0 )

.

(21)

Equating the two slopes, s < 0, in Equations (20) and (21), simplifying, and substituting T for
the absolute value of the surface tension difference between points 1 and 2,
𝛥𝑇
𝑐
𝑙𝑛( 2 )
𝑐1

=

𝛽𝑇𝑚𝑎𝑥
𝑐
𝑙𝑛( 𝑚𝑎𝑥 )

.

(22)

𝑐0

The logarithmic function of constants, c0 and cmax , can be determined from experimental data as
𝑙𝑛 (

𝑐𝑚𝑎𝑥
𝑐0

)=

𝛽𝑇𝑚𝑎𝑥
𝛥𝑇

𝑐

𝑙𝑛 (𝑐2 ) .

(23)

1

Using Equation (9), substituting from Equation (23), and using the data for ln(c2/c1) in Table 1,
𝑏=𝛽

2
𝑐
𝑙𝑛( 𝑚𝑎𝑥 )

2

= 𝛽 𝛽𝑇𝑚𝑎𝑥

𝑐0

𝛥𝑇

𝑐
𝑙𝑛( 2 )
𝑐1

=

𝛥𝑇
𝑇𝑚𝑎𝑥
𝑐
𝑙𝑛( 2 )
𝑐1

2

.

(24)

In this way one can estimate constant b from the measured relative surface tension reduction,
T/Tmax , and the surfactant concentration ratio, c2/c1 , which produced T/Tmax experimentally.
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